SOURCE: Stratos Product Development

Stratos Product Development

July 14, 2011 15:37 ET

Stratos Product Development and Response Biomedical Partner to Develop Internationalized Diagnostic Device for Distribution to China and Other Markets

SEATTLE, WA--(Marketwire - Jul 14, 2011) - Stratos Product Development, LLC today announced its continued partnership with Response Biomedical in the development of an internationalized version of the Rapid Analyte Measurement Platform (RAMP®) 200 clinical diagnostic system, building on the success of the North American version of the product released in 2008.

In April, Response Biomedical announced it received product registration from China's State Food & Drug Administration (SFDA) to sell the RAMP 200 Reader in the Chinese market. Per the April 28 press release, the new, internationalized version of the RAMP 200 Reader is "a pivotal step forward" in increasing Response Biomedical's market penetration in this region. The market potential for diagnostic products in China is rapidly expanding and Response has the necessary resources and partnerships in place to meet the growing market demand for the RAMP 200 and cardiac diagnostic tests. They have distribution agreements in place to support product representation in China for the next two years.

"Throughout the development life cycle, Stratos Product Development has provided excellent design control and creative solutions to complex development challenges, and they have exceeded our expectations within tight timelines. Their most recent efforts in our translation project will support our continued efforts to expand our business in China and the rest of the world," Dr. Barb Kinnaird, Senior Director, Operations, Response Biomedical, said.

Stratos and Response Biomedical partnered on the initial development of the RAMP 200, a novel lateral flow immunoassay platform that provides quantitative results in minutes. The RAMP 200 was designed by the Stratos team to incorporate unique features such as multi-port capability (up to 36 tests per hour), the ability to run multiple patients simultaneously, as well as multiple assays on one patient. What's more, the RAMP 200 features a PC-based platform for easy software upgrades, easy-to-read touch screen technology and a detailed configuration manager, data management and interface options. The instrument also features an automated Instrument Quality Control and a complex Liquid Quality Control test that verifies assays are running correctly, ensuring accurate clinically relevant and actionable results every time.

"Stratos' expertise in user interface design, software and instrumentation engineering in combination with Response Biomedical's unique assay platform allows for a flexible and compelling solution that meets the clinical needs for both Western and developing markets across a wide range of diagnostic applications. It has been very rewarding to combine our two companies' strengths over the past five years to create multiple offerings for worldwide distribution," Sean MacLeod, President, Stratos Product Development, said.

The end result is a device that provides rapid, reliable test results generated at the point-of-care, allowing the physician to quickly diagnose and initiate treatments that can improve clinical outcomes and save lives. Read the case study.

Stratos Product Development and Response Biomedical will showcase the RAMP 200 device at the AACC Clinical Lab Expo in Atlanta, July 26-28, 2011 in booth #4007.

About Stratos Product Development, LLC
For 25 years, Stratos Product Development has been supporting the most innovative companies in designing their breakthrough technologies. Whether you need a full-system development team or are looking for a specific area of expertise, Stratos can help. We offer strong concept and architecture capabilities and integrated product development including hardware, software, mechanical, quality engineering and project management. Our systems-based approach enables us to reduce time-to-market, mitigate development risks and create compelling product solutions for unmet needs in the marketplace.

About Response Biomedical
Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP® Platform for clinical and environmental applications. RAMP® represents a new paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use.

Contact Information